SAVINI, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 3.118
EU - Europa 2.414
AS - Asia 1.304
SA - Sud America 153
AF - Africa 66
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.067
Nazione #
US - Stati Uniti d'America 3.049
RU - Federazione Russa 545
CN - Cina 514
GB - Regno Unito 507
SG - Singapore 388
IE - Irlanda 357
SE - Svezia 221
DE - Germania 202
UA - Ucraina 198
FR - Francia 148
BR - Brasile 127
VN - Vietnam 104
HK - Hong Kong 92
FI - Finlandia 66
KR - Corea 60
IT - Italia 54
CA - Canada 48
IN - India 42
ZA - Sudafrica 41
ES - Italia 32
TR - Turchia 25
CZ - Repubblica Ceca 22
PL - Polonia 16
BD - Bangladesh 11
BE - Belgio 11
MX - Messico 11
AR - Argentina 10
JP - Giappone 9
IR - Iran 8
IQ - Iraq 7
NG - Nigeria 7
UZ - Uzbekistan 6
CO - Colombia 5
ID - Indonesia 5
NL - Olanda 5
KE - Kenya 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
AU - Australia 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
OM - Oman 2
PH - Filippine 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BB - Barbados 1
BN - Brunei Darussalam 1
CH - Svizzera 1
EC - Ecuador 1
EG - Egitto 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
LK - Sri Lanka 1
NI - Nicaragua 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 7.067
Città #
Southend 419
Dublin 356
Dallas 297
Fairfield 274
Ashburn 272
Chandler 233
Singapore 217
Jacksonville 154
Santa Clara 139
Woodbridge 139
San Jose 129
Beijing 127
Moscow 119
Wilmington 105
Seattle 103
Ann Arbor 92
Houston 92
Hong Kong 90
Cambridge 88
Hefei 83
Los Angeles 66
Seoul 60
Nanjing 59
Princeton 57
New York 52
The Dalles 40
Johannesburg 38
Munich 37
Ho Chi Minh City 36
Menlo Park 34
Boardman 30
Helsinki 25
Lauterbourg 24
London 24
Shanghai 24
Siena 24
San Mateo 21
Brno 19
Fremont 19
Hanoi 19
Málaga 19
Ottawa 19
Shenyang 17
Buffalo 14
Izmir 14
Nanchang 14
San Diego 13
Washington 13
Düsseldorf 12
Warsaw 12
Bengaluru 11
Brussels 11
Dearborn 11
Orem 11
São Paulo 11
Hebei 10
Jiaxing 10
Kunming 10
Mumbai 10
Tianjin 10
Turku 10
Frankfurt am Main 9
Manchester 9
Montreal 9
Changsha 8
Lancaster 8
Tokyo 8
Toronto 8
Abuja 7
Auburn Hills 7
Jinan 7
Taizhou 7
Atlanta 6
Chennai 6
Council Bluffs 6
Da Nang 6
Guangzhou 6
Hangzhou 6
Newark 6
Paris 6
Baghdad 5
Brooklyn 5
Chicago 5
Denver 5
Haiphong 5
Mexico City 5
Redwood City 5
Roubaix 5
San Francisco 5
Tashkent 5
Amsterdam 4
Ankara 4
Belgrade 4
Biên Hòa 4
Calgary 4
Charlotte 4
Mashhad 4
Ningbo 4
Norwalk 4
Phoenix 4
Totale 4.723
Nome #
Structural study of ribonucleotide reductase inhibitor hydrazones. Synthesis and X-ray diffraction analysis of a copper(II)-benzoylpyridine-2-quinolinyl hydrazone complex 280
Optimization of 4-Aminoquinoline/Clotrimazole-Based Hybrid Antimalarials: Further Structure-Activity Relationships, in vivo Studies, and Preliminary Toxicity Profiling 275
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents 272
Mimicking the Intramolecular Hydrogen Bond: Synthesis, Biological Evaluation, and Molecular Modeling of Benzoxazines and Quinazolines as Potential Antimalarial Agents 271
Chelating agents as potential antitumorals. 2-quinolylhydrazones and bis-2-quinolylhydrazones. I 264
Microwave-assisted synthesis of 4-quinolylhydrazines followed by nickel boride reduction: a convenient approach to 4-aminoquinolines and derivatives 261
Development of Antitubercular Compounds Based on a 4-Quinolylhydrazone Scaffold. Further Structure-activity Relationship Studies 259
New 1-[quinolyl(4)]-1,2,3-triazoles: synthesis and evaluation of antiinflammatory and analgesic properties. II 245
Specific Targeting of Hepatitis C Virus NS3 RNA Helicase. Discovery of the Potent and Selective Competitive Nucleotide-Mimicking Inhibitor QU663 245
Design and Synthesis of Potent Antimalarial Agents Based on Clotrimazole Scaffold: Exploring an Innovative Pharmacophore 245
ANTIMALARIAL AGENTS HAVING POLYAROMATIC STRUCTURE 242
Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling 239
Malaria chemotherapy: recent advances in drug development 238
High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones 238
Pyrazolo[4,3-c]quinolines. Synthesis and specific inhibition of benzodiazepine receptor binding (Note I) 237
Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors 235
Chelating agents as potential antitumorals: alfa-(N)-heterocyclic hydrazones and bis-alfa-(N)-heterocyclic hydrazones 227
Quinolylhydrazones as novel inhibitors of Plasmodium falciparum serine protease PfSUB1 223
Clotrimazole Scaffold as an Innovative Pharmacophore Towards Potent Antimalarial Agents: Design, Synthesis, Biological and Structure-Activity Relationship Studies 215
Pyrroloquinoxaline hydrazones as fluorescent probes for amyloid fibrils 211
Application of near infrared reflectance spectroscopy (NIRS) to several antibiotic compounds 209
Application of NIRS to the control of pharmaceuticals identification and assay of several primary materials 208
Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors 204
New quinoline derivatives: synthesis and evaluation for antiinflammatory and analgesic properties - Note I 199
Pyrazolo[4,3-c]quinolines. Synthesis and specific inhibition of benzodiazepine receptor binding. Note II 198
Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase 198
New alpha-(N)-heterocyclichydrazones: evaluation of anticancer, anti-HIV and antimicrobial activity 193
Application of Near-Infrared Reflectance Analysis (NIRA) to the integrated control of antibiotics tablet production 187
Rational design of the first difluorostatone-based PfSUB1 inhibitors 183
Thin layer chromatography in pharmaceutical quality control. Assay of inosiplex in different pharmaceutical forms 169
Tridentate N-N-N chelating systems as potential antitumor agents [Sistemi chelanti tridentati N*-N*-N* quali potenziali agenti antitumorali] 94
On the isomerism/tautomerism of hydrazones. Crystal structures, study in solution and theoretical calculation of new series of α-N-heterocyclic hydrazones 87
null 39
Synthesis and antitubercular evaluation of 4-quinolylhydrazones 2
High affinity central benzodiazepine receptor ligands. Part 3 : insights into the pharmacophore and pattern recognition study of intrinsic activities of pyrazolo [4,3-c]quinolin-3-ones 1
Totale 7.093
Categoria #
all - tutte 20.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 0 0 33
2021/2022406 36 61 26 54 17 4 22 14 14 45 31 82
2022/2023731 38 81 87 111 74 134 12 68 72 24 22 8
2023/2024559 19 14 57 25 25 177 193 3 2 9 1 34
2024/2025960 27 46 138 30 137 37 8 45 108 22 86 276
2025/20262.118 175 289 276 298 478 81 272 51 50 101 40 7
Totale 7.093